Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cell-derived microparticles as hemostatic agents for control of hemorrhage and treatment of bleeding disorders

Cell-derived microparticles as hemostatic agents for control of hemorrhage and treatment of bleeding disorders

US Patent 8105632 · Granted Jan 31, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cold-rolled steel sheet having excellent bendability and hole expandability and 2025
Method of preventing and treating chemotherapy-induced alopecia2025
Method of manufacturing high-strength steel sheet having excellent processabilit2023
High-strength steel sheet having excellent processability and method for manufac2022
Map calendar graphical user interface with dynamic time mold functionality2022
Method of treating or preventing tumors of the central nervous system2022
High-strength steel sheet with excellent crashworthiness characteristics and for2022
High-strength steel sheet with excellent crashworthiness characteristics and for2022
Vitamin D3 and analogs thereof for treating alopecia2022
Methods of treatment of cancer by continuous infusion of coenzyme Q102022
Composition comprising red cell-derived microparticles and method of treating ex2022
Composition comprising red cell-derived microparticles and method of treating ex2022